Cash Flow Stocks With DCF Upside As Higher Bond Yields Test Valuations

Fast Growing ASX Stocks With High Insider Ownership Worth Watching

Telix Appoints David Gill as Chair

Telix Completes Enrollment in Phase 3 BiPASS Study, Aligns with FDA on NDA Pathway

Telix Pharmaceuticals Shares Rise 5.3% as Analyst Highlights BiPASS Trial and FDA Pathway

Sector Update: Healthcare Stocks Advance Wednesday Afternoon

TLX Stock Clocks 5% Gain This Week Ahead Of FDA Decision On Brain Cancer Imaging Agent

Telix to Present at the Morgan Stanley 24th Annual Global Healthcare Conference and H.C. Wainwright 28th Annual Global Investment Conference

FDA Approves Telix's Brain Cancer Imaging Drug Pixclara

FDA Approves Telix’s Brain Cancer Imaging Drug Pixclara